» TECHNOVIEW® Arixtra® Cal Set

HEMOSTASIS COAGULATION ROUTINE ANTICOAGULANT MONITORING ANTI-XA ARIXTRA®

TECHNOVIEW® Arixtra® Cal Set

Lyophilized plasmas

Calibration plasma for the Arixtra® assay

TECHNOVIEW® Arixtra® Cal Set calibration plasmas are prepared from citrated plasmas supplemented with different concentrations of Arixtra®.
The kit includes a set of 5 calibrators from 0 to 2 µg / mL, optimized for anti-FXa methods.

Access on the manufacturer's website TECHNOCLONE

Reference	4-5090010
Presentation	Vial
Format	5 x 1.0 mL
Quote

Price list, safety data sheets and notices are accessible to our registered customers.

Reference	Presentation	Format	Quote	Product sheet
4-5090010	Vial	5 x 1.0 mL

Price list, safety data sheets and notices are accessible to our registered customers.

Arixtra® (fondaparinux sodium), is a pentasaccharide derived from the portion of heparin that binds to antithrombin and inhibits FXa.
Arixtra® is obtained by chemical synthesis, while anticoagulants of the heparin family are of animal origin.
It is used as a preventive measure for venous thromboembolic events or used as a treatment for venous thrombosis.

TECHNOVIEW® Arixtra® Cal Set and Cont Low and High plasmas are prepared from citrated plasmas supplemented with different concentrations of Arixtra® (fondaparinux sodium).
They allow validation of the calibration curve for Arixtra® assays in plasma, in particular with anti-FXa assay methods.
The calibration curve encompasses the current concentrations obtained during treatment with Arixtra®.

- 5 vials x 1 mL lyophilized plasma

TECHNOVIEW® Arixtra® Cont High
TECHNOVIEW® Arixtra® Cont Low

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer
	Distributor.

HEMOSTASIS COAGULATION ROUTINE ANTICOAGULANT MONITORING ANTI-XA ARIXTRA®